The effect of exercise and metformin treatment on circulating free DNA in pregnancy

Placenta

Volumn 35, Issue 12, 2014, Pages 989-993

  Christiansen, S C ^a,b   Vanky, E ^a,b   Klungland, H ^b   Stafne, S N ^a,b   Morkved S ^a,b   Salvesen, K A ^b,c   Saether M ^b   Carlsen, S M ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cell free fetal DNA; Cell free maternal DNA; Cell free total DNA training in pregnancy; Metformin; Polycystic ovary syndrome

Indexed keywords

CELL FREE FETAL DNA; CELL FREE MATERNAL DNA; DNA; METFORMIN; PLACEBO; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; DRUG EFFECT; ENDURANCE TRAINING; EXERCISE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY POLYCYSTIC DISEASE; PHYSICAL STRESS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; STRETCHING EXERCISE; ADOLESCENT; BLOOD; FIRST TRIMESTER PREGNANCY; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; DNA; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY TRIMESTER, FIRST; YOUNG ADULT;

EID: 84922277241     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.09.010     Document Type: Article

References (37)

1. Rijnders RJ, Van Der Luijt RB, Peters ED, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003;23(13):1042-4.
2. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64(1):218-24.
3. Bianchi DW, Wataganara T, Lapaire O, Tjoa ML, Maron JL, Larrabee PB, et al. Fetal nucleic acids in maternal body fluids: an update. Ann N Y Acad Sci 2006;1075:63-73.
4. Alberry M, Maddocks D, Jones M, Abdel HM, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27(5):415-8.
5. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, et al. Twostage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190(3):707-13.
6. Yin A, Ng EH, Zhang X, He Y, Wu J, Leung KY. Correlation of maternal plasma total cell-free DNA and fetal DNA levels with short term outcome of firsttrimester vaginal bleeding. Hum Reprod 2007;22(6):1736-43.
7. Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009;29(12):1118-22.
8. Farina A, Leshane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193(2):421-5.
9. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352(9144):1904-5.
10. Pan PD, Peter I, Lambert-Messerlian GM, Canick JA, Bianchi DW, Johnson KL. Cell-free fetal DNA levels in pregnancies conceived by IVF. Hum Reprod 2005;20(11):3152-6.
11. Lapaire O, Volgmann T, Grill S, Hosli I, Zanetti-Daellenbach R, Zhong XY, et al. Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci 2009;16(3):274-9.
12. Lapaire O, Volgmann T, Huang D, Hahn S, Holzgreve W, Zhong XY. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet Gynecol 2007;110(6):1358-63.
13. Beiter T, Fragasso A, Hudemann J, Niess AM, Simon P. Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo. Clin Chem 2011;57(4):633-6.
14. Schlutter JM, Hatt L, Bach C, Kirkegaard I, Kolvraa S, Uldbjerg N. The cell-free fetal DNA fraction in maternal blood decreases after physical activity. Prenat Diagn 2014;34(4):341-4.
15. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12(6):673-83.
16. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011;343:d6309.
17. de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998;76(1):91-5.
18. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011;204(6): 558-66.
19. Vanky E, DE ZF, Diaz M, Ibanez L, Carlsen SM. On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome e an epianalysis. Acta Obstet Gynecol Scand 2012;91(12):1460-4.
20. De L, V, Musacchio MC, Piomboni P, Di SA, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol 2011;157(1): 63-6.
21. Palomba S, Russo T, Falbo A, Di CA, Amendola G, Mazza R, et al. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J Clin Endocrinol Metab 2012;97(7):2441-9.
22. Stafne SN, Salvesen KA, Romundstad PR, Eggebo TM, Carlsen SM, Morkved S. Regular exercise during pregnancy to prevent gestational diabetes: a randomized controlled trial. Obstet Gynecol 2012;119(1):29-36.
23. Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogoy K, Kleggetveit O, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95(12):E448-55.
24. Vanky E, Nordskar JJ, Leithe H, Hjorth-Hansen AK, Martinussen M, Carlsen SM. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo. BJOG 2012;119(11):1403-9.
25. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. J Am Med Assoc 2004;291(9):1114-9.
26. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM, Keer JT. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005;51(2):312-20.
27. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184(3):414-9.
28. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51(9):1598-604.
29. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62(4):768-75.
30. Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Verderio P, et al. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 2005;97(24):1848-50.
31. Breitbach S, Tug S, Simon P. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med 2012;42(7):565-86.
32. Palomba S, Falbo A, La Sala GB. Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and metaanalysis of randomised controlled trials. BJOG 2013;120(3):267-76.
33. Palomba S, Falbo A, Orio Jr F, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and metaanalysis of randomized controlled trials. Fertil Steril 2009;92(5):1646-58.
34. Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippelainen M, Perheentupa A, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 2012;97(5): 1492-500.
35. Haghiac M, Vora NL, Basu S, Johnson KL, Presley L, Bianchi DW, et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obes (Silver Spring) 2012;20(11):2213-9.
36. Carlsen SM, Martinussen MP, Vanky E. Metformin's effect on first-year weight gain: a follow-up study. Pediatrics 2012;130(5):e1222-6.
37. Ganie MA, Khurana ML, Eunice M, Gupta N, Gulati M, Dwivedi SN, et al. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab 2004;89(6):2756-62.